Gerson Therapy (PDQ): Patient Version
government report · 2015
LINK
SUMMARY
National Cancer Institute patient-facing evidence summary, fetched directly. It reports reviews of 60 patients' cases that did not demonstrate benefit, notes that no clinical trials support the 1995 retrospective melanoma-survival findings, records three published deaths potentially related to coffee enemas, and states that FDA has not approved Gerson therapy to treat cancer or any other disease.
NOTES
The National Cancer Institute’s patient-facing evidence summary on Gerson therapy, fetched directly, used alongside the health-professional version for the evidentiary-failure narrative.